{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:02:00Z","timestamp":1789606920542,"version":"build-2803163510"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":114,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["NET-2013-02355263"],"award-info":[{"award-number":["NET-2013-02355263"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2022X7NH4W"],"award-info":[{"award-number":["PRIN 2022X7NH4W"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurodevelop Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Phelan-McDermid syndrome (PMS) is caused in the majority of cases by the loss or mutation of one allele of the\n                      <jats:italic>SHANK3<\/jats:italic>\n                      gene, located in human chr 22q13.33. PMS displays large interindividual differences in clinical severity and longitudinal trajectory. Other genes located in this chromosomal region are known to contribute to the clinical phenotype (\n                      <jats:italic>CELSR1<\/jats:italic>\n                      ,\n                      <jats:italic>TCF20<\/jats:italic>\n                      ) in patients with larger deletions. The aim of this study is to identify clinically-relevant phenotypic features significantly influenced by the size of chromosome 22q terminal deletion and to identify new potential candidate genes likely to be involved in these phenotypic effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Genotype\u2013phenotype correlations were investigated in 63 PMS patients directly ascertained by deep clinical phenotyping and determination of deletion size (Agilent CGH-array 180K or 400K). Patients were partitioned into eleven categories, based on deletion size (Mb). Phenotypic variables significantly influenced by deletion size were initially detected by exact \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      (10,000 iterations) and Kendall\u2019s Tau. Candidate genes were then sought using: (a) ROC curves for binary dichotomous variables; (b) best separation threshold for quantitative variables.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Phenotypic variables significantly associated with chromosome 22q deletion size in our sample include: expressive language (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001); motor development timing (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001); gait (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001); muscle strength (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01); social cognition, encompassing eye contact, exchange gesture, and joint attention (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001\u2014&lt;\u20090.05); infectious diseases coincident with the onset of behavioral manifestations (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001); brain structural abnormalities on MRI (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001); dysmorphisms (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001); renal and urinary malformations (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01); comorbid lifelong bipolar disorder (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). The best separation thresholds for many of these variables were located within or nearby genes playing important morphogenetic (\n                      <jats:italic>PLXNB2, TAFA5<\/jats:italic>\n                      ) or neurodevelopmental roles (\n                      <jats:italic>BRD1<\/jats:italic>\n                      ,\n                      <jats:italic>TBC1D22A<\/jats:italic>\n                      ,\n                      <jats:italic>ATXN10<\/jats:italic>\n                      and\/or\n                      <jats:italic>FBLN1<\/jats:italic>\n                      ). For renal malformations, the two best thresholds point toward one long non-coding RNA and a cluster of antisense RNAs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The genes identified in this study appear as strong candidates to contribute to the PMS phenotype, by conferring an additional layer of abnormal neurodevelopment and impaired morphogenesis to the disruptive effects produced by\n                      <jats:italic>SHANK3<\/jats:italic>\n                      haploinsufficiency.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s11689-026-09708-x","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T08:26:20Z","timestamp":1779783980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chromosome 22q13 terminal deletion size is associated with relevant clinical features in a sample of 63 Italian patients with Phelan-McDermid syndrome"],"prefix":"10.1186","volume":"18","author":[{"given":"Laura","family":"Sandoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fethia","family":"Chehbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Asta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Camia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Ricciardello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Tomaiuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cucinotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Turriziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Boncoddo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Baccarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Picinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Castronovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Lintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio Stefano","family":"Piras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pelagatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Banchelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo Cuoghi","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio M.","family":"Persico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"9708_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/1096-8628(20010615)101:2<91::AID-AJMG1340>3.0.CO;2-C","volume":"101","author":"MC Phelan","year":"2001","unstructured":"Phelan MC, Rogers RC, Saul RA, Stapleton GA, Sweet K, McDermid H, et al. 22q13 deletion syndrome. Am J Med Genet. 2001;101:91\u20139.","journal-title":"Am J Med Genet"},{"issue":"3\u20135","key":"9708_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000334260","volume":"2","author":"K Phelan","year":"2011","unstructured":"Phelan K, McDermid HE. The 22q13.3 deletion syndrome (Phelan-McDermid Syndrome). Mol Syndromol. 2011;2(3\u20135):186\u2013201.","journal-title":"Mol Syndromol."},{"issue":"1","key":"9708_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2040-2392-4-18","volume":"4","author":"L Soorya","year":"2013","unstructured":"Soorya L, Kolevzon A, Zweifach J, Lim T, Dobry Y, Schwartz L, et al. Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency. Mol Autism. 2013;4(1):18.","journal-title":"Mol Autism"},{"key":"9708_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13229-018-0205-9","volume":"9","author":"S De Rubeis","year":"2018","unstructured":"De Rubeis S, Siper PM, Durkin A, Weissman J, Muratet F, Halpern D, et al. Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations. Mol Autism. 2018;9:31.","journal-title":"Mol Autism"},{"key":"9708_CR5","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1111\/epi.13506","volume":"57","author":"JL Holder","year":"2016","unstructured":"Holder JL, Quach MM. The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK 3 loss\u2010of\u2010function mutations. Epilepsia. 2016;57:1651\u20139.","journal-title":"Epilepsia"},{"key":"9708_CR6","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.seizure.2014.06.008","volume":"23","author":"MG Figura","year":"2014","unstructured":"Figura MG, Coppola A, Bottitta M, Calabrese G, Grillo L, Luciano D, et al. Seizures and EEG pattern in the 22q13.3 deletion syndrome: clinical report of six Italian cases. Seizure. 2014;23:774\u20139.","journal-title":"Seizure."},{"key":"9708_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ajmg.a.33253","volume":"152A","author":"SU Dhar","year":"2010","unstructured":"Dhar SU, Del Gaudio D, German JR, Peters SU, Ou Z, Bader PI, et al. 22q13.3 deletion syndrome: clinical and molecular analysis using array CGH. Am J Med Genet Pt A. 2010;152A:573\u201381.","journal-title":"Am J Med Genet Pt A."},{"key":"9708_CR8","doi-asserted-by":"publisher","first-page":"e376","DOI":"10.1542\/peds.2007-2584","volume":"122","author":"A Philippe","year":"2008","unstructured":"Philippe A, Boddaert N, Vaivre-Douret L, Robel L, Danon-Boileau L, Malan V, et al. Neurobehavioral profile and brain imaging study of the 22q13.3 deletion syndrome in childhood. Pediatrics. 2008;122:e376\u201382.","journal-title":"Pediatrics"},{"key":"9708_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1086\/321293","volume":"69","author":"MC Bonaglia","year":"2001","unstructured":"Bonaglia MC, Giorda R, Borgatti R, Felisari G, Gagliardi C, Selicorni A, et al. Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am J Hum Genet. 2001;69:261\u20138.","journal-title":"Am J Hum Genet"},{"key":"9708_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ajmg.a.35700","volume":"161","author":"KA Aldinger","year":"2013","unstructured":"Aldinger KA, Kogan J, Kimonis V, Fernandez B, Horn D, Klopocki E, et al. Cerebellar and posterior fossa malformations in patients with autism-associated chromosome 22q13 terminal deletion. Am J Med Genet Pt A. 2013;161:131\u20136.","journal-title":"Am J Med Genet Pt A"},{"issue":"2","key":"9708_CR11","doi-asserted-by":"publisher","first-page":"zsw062","DOI":"10.1093\/sleep\/zsw062","volume":"40","author":"D Bro","year":"2017","unstructured":"Bro D, O\u2019Hara R, Primeau M, Hanson-Kahn A, Hallmayer J, Bernstein JA. Sleep disturbances in individuals with Phelan-McDermid Syndrome: correlation with caregivers\u2019 sleep quality and daytime functioning. Sleep. 2017;40(2):zsw062.","journal-title":"Sleep"},{"key":"9708_CR12","doi-asserted-by":"publisher","first-page":"e42819","DOI":"10.7554\/eLife.42819","volume":"8","author":"AM Ingiosi","year":"2019","unstructured":"Ingiosi AM, Schoch H, Wintler T, Singletary KG, Righelli D, Roser LG, et al. Shank3 modulates sleep and expression of circadian transcription factors. Elife. 2019;8:e42819.","journal-title":"Elife"},{"key":"9708_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/cge.14364","volume":"104","author":"MS Smith","year":"2023","unstructured":"Smith MS, Sarasua SM, Rogers C, Phelan K, Boccuto L. Lymphedema is associated with CELSR1 in Phelan\u2013McDermid syndrome. Clin Genet. 2023;104:472\u20138.","journal-title":"Clin Genet"},{"key":"9708_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s11689-019-9273-1","volume":"11","author":"CI Samogy-Costa","year":"2019","unstructured":"Samogy-Costa CI, Varella-Branco E, Monfardini F, Ferraz H, Fock RA, Barbosa RHA, et al. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case. J Neurodevelop Disord. 2019;11:13.","journal-title":"J Neurodevelop Disord"},{"key":"9708_CR15","doi-asserted-by":"publisher","first-page":"104754","DOI":"10.1016\/j.ejmg.2023.104754","volume":"66","author":"M Sch\u00f6n","year":"2023","unstructured":"Sch\u00f6n M, Lapunzina P, Nevado J, Mattina T, Gunnarsson C, Hadzsiev K, et al. Definition and clinical variability of SHANK3-related Phelan-McDermid syndrome. Eur J Med Genet. 2023;66:104754.","journal-title":"Eur J Med Genet"},{"key":"9708_CR16","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00439-014-1423-7","volume":"133","author":"SM Sarasua","year":"2014","unstructured":"Sarasua SM, Boccuto L, Sharp JL, Dwivedi A, Chen C-F, Rollins JD, et al. Clinical and genomic evaluation of 201 patients with Phelan\u2013McDermid syndrome. Hum Genet. 2014;133:847\u201359.","journal-title":"Hum Genet"},{"key":"9708_CR17","unstructured":"PMSF By The Numbers. Phelan-McDermid Syndrome Foundation. Available from: https:\/\/pmsf.org\/pmsf-by-the-numbers\/. Cited 2024 Jul 25."},{"key":"9708_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2040-2392-4-17","volume":"4","author":"C Betancur","year":"2013","unstructured":"Betancur C, Buxbaum JD. SHANK3 haploinsufficiency: a \u201ccommon\u201d but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders. Mol Autism. 2013;4:17.","journal-title":"Mol Autism"},{"key":"9708_CR19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/jmedgenet-2011-100225","volume":"48","author":"SM Sarasua","year":"2011","unstructured":"Sarasua SM, Dwivedi A, Boccuto L, Rollins JD, Chen C-F, Rogers RC, et al. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome). J Med Genet. 2011;48:761\u20136.","journal-title":"J Med Genet"},{"key":"9708_CR20","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/jmg.40.8.575","volume":"40","author":"HL Wilson","year":"2003","unstructured":"Wilson HL, Wong ACC, Shaw SR, Tse W-Y, Stapleton GA, Phelan MC, et al. Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3\/PROSAP2 in the major neurological symptoms. J Med Genet. 2003;40:575\u201384.","journal-title":"J Med Genet"},{"key":"9708_CR21","doi-asserted-by":"publisher","first-page":"34839","DOI":"10.1074\/jbc.M111.258384","volume":"286","author":"C Verpelli","year":"2011","unstructured":"Verpelli C, Dvoretskova E, Vicidomini C, Rossi F, Chiappalone M, Schoen M, et al. Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. J Biol Chem. 2011;286:34839\u201350.","journal-title":"J Biol Chem"},{"key":"9708_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/NDT.S30506","volume":"8","author":"WM Verhoeven","year":"2012","unstructured":"Verhoeven WM, Egger JI, Willemsen MH, de Leijer GJ, Kleefstra T. Phelan-McDermid syndrome in two adult brothers: atypical bipolar disorder as its psychopathological phenotype? Neuropsychiatr Dis Treat. 2012;8:175\u20139.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"9708_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000339119","volume":"3","author":"A Denayer","year":"2012","unstructured":"Denayer A, Van Esch H, De Ravel T, Frijns J-P, Van Buggenhout G, Vogels A, et al. Neuropsychopathology in 7 patients with the 22q13 deletion syndrome: presence of bipolar disorder and progressive loss of skills. Mol Syndromol. 2012;3:14\u201320.","journal-title":"Mol Syndromol"},{"key":"9708_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13229-019-0291-3","volume":"10","author":"A Kolevzon","year":"2019","unstructured":"Kolevzon A, Delaby E, Berry-Kravis E, Buxbaum JD, Betancur C. Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature. Mol Autism. 2019;10:50.","journal-title":"Mol Autism"},{"key":"9708_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s11689-020-9309-6","volume":"12","author":"TM Kohlenberg","year":"2020","unstructured":"Kohlenberg TM, Trelles MP, McLarney B, Betancur C, Thurm A, Kolevzon A. Psychiatric illness and regression in individuals with Phelan-McDermid syndrome. J Neurodev Disord. 2020;12:7.","journal-title":"J Neurodev Disord"},{"key":"9708_CR26","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1017\/neu.2024.46","volume":"37","author":"MA Colijn","year":"2024","unstructured":"Colijn MA. Phelan-McDermid syndrome-associated psychosis: a systematic review. Acta Neuropsychiatr. 2024;37:e15.","journal-title":"Acta Neuropsychiatr"},{"key":"9708_CR27","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1017\/S0033291725100536","volume":"55","author":"I Conti","year":"2025","unstructured":"Conti I, Ramachandran K, Badenoch JB, Fanshawe JB, Rengasamy E, Cross B, et al. Genetic abnormalities in catatonia: a systematic review. Psychol Med. 2025;55:e164.","journal-title":"Psychol Med"},{"key":"9708_CR28","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/ajmg.b.32528","volume":"174","author":"CA De Sena","year":"2017","unstructured":"De Sena CA, Degenhardt F, Strohmaier J, Lang M, Weiss B, Roeth R, et al. Investigation of SHANK3 in schizophrenia. Am J Med Genet Pt B. 2017;174:390\u20138.","journal-title":"Am J Med Genet Pt B"},{"key":"9708_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ejhg.2012.175","volume":"21","author":"L Boccuto","year":"2013","unstructured":"Boccuto L, Lauri M, Sarasua SM, Skinner CD, Buccella D, Dwivedi A, et al. Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. Eur J Hum Genet. 2013;21:310\u20136.","journal-title":"Eur J Hum Genet"},{"key":"9708_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1542\/peds.114.2.451","volume":"114","author":"MA Manning","year":"2004","unstructured":"Manning MA, Cassidy SB, Clericuzio C, Cherry AM, Schwartz S, Hudgins L, et al. Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum. Pediatrics. 2004;114:451\u20137.","journal-title":"Pediatrics"},{"key":"9708_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.braindev.2012.05.013","volume":"35","author":"S Uchino","year":"2013","unstructured":"Uchino S, Waga C. SHANK3 as an autism spectrum disorder-associated gene. Brain Dev. 2013;35:106\u201310.","journal-title":"Brain Dev"},{"key":"9708_CR32","doi-asserted-by":"publisher","first-page":"e1004580","DOI":"10.1371\/journal.pgen.1004580","volume":"10","author":"CS Leblond","year":"2014","unstructured":"Leblond CS, Nava C, Polge A, Gauthier J, Huguet G, Lumbroso S, et al. Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments. PLoS Genet. 2014;10:e1004580.","journal-title":"PLoS Genet"},{"key":"9708_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/ajmg.b.30822","volume":"150B","author":"J Gauthier","year":"2009","unstructured":"Gauthier J, Spiegelman D, Piton A, Lafreni\u00e8re RG, Laurent S, St-Onge J, et al. Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet Pt B. 2009;150B:421\u20134.","journal-title":"Am J Med Genet Pt B"},{"key":"9708_CR34","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1086\/522590","volume":"81","author":"R Moessner","year":"2007","unstructured":"Moessner R, Marshall CR, Sutcliffe JS, Skaug J, Pinto D, Vincent J, et al. Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet. 2007;81:1289\u201397.","journal-title":"Am J Hum Genet"},{"key":"9708_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s13023-020-01592-5","volume":"15","author":"N Xu","year":"2020","unstructured":"Xu N, Lv H, Yang T, Du X, Sun Y, Xiao B, et al. A 29 Mainland Chinese cohort of patients with Phelan\u2013McDermid syndrome: genotype\u2013phenotype correlations and the role of SHANK3 haploinsufficiency in the important phenotypes. Orphanet J Rare Dis. 2020;15:335.","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"9708_CR36","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/ajmg.a.36513","volume":"164A","author":"V Disciglio","year":"2014","unstructured":"Disciglio V, Lo Rizzo C, Mencarelli MA, Mucciolo M, Marozza A, Di Marco C, et al. Interstitial 22q13 deletions not involving SHANK3 gene: a new contiguous gene syndrome. Am J Med Genet A. 2014;164A(7):1666\u201376.","journal-title":"Am J Med Genet A"},{"key":"9708_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13023-022-02180-5","volume":"17","author":"K Phelan","year":"2022","unstructured":"Phelan K, Boccuto L, Powell CM, Boeckers TM, van Ravenswaaij-Arts C, Rogers RC, et al. Phelan-McDermid syndrome: a classification system after 30 years of experience. Orphanet J Rare Dis. 2022;17:27.","journal-title":"Orphanet J Rare Dis"},{"key":"9708_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41431-017-0042-x","volume":"26","author":"AR Mitz","year":"2018","unstructured":"Mitz AR, Philyaw TJ, Boccuto L, Shcheglovitov A, Sarasua SM, Kaufmann WE, et al. Identification of 22q13 genes most likely to contribute to Phelan McDermid syndrome. Eur J Hum Genet. 2018;26:293\u2013302.","journal-title":"Eur J Hum Genet"},{"key":"9708_CR39","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1002\/ajmg.a.62222","volume":"185","author":"A Ricciardello","year":"2021","unstructured":"Ricciardello A, Tomaiuolo P, Persico AM. Genotype-phenotype correlation in Phelan-McDermid syndrome: a comprehensive review of chromosome 22q13 deleted genes. Am J Med Genet A. 2021;185:2211\u201333.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"9708_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13229-024-00619-z","volume":"15","author":"R Yin","year":"2024","unstructured":"Yin R, Wack M, Hassen-Khodja C, McDuffie MT, Bliss G, Horn EJ, et al. Phenome-wide profiling identifies genotype-phenotype associations in Phelan-McDermid syndrome using family-sourced data from an international registry. Mol Autism. 2024;15(1):40.","journal-title":"Mol Autism"},{"key":"9708_CR41","doi-asserted-by":"publisher","first-page":"e0253859","DOI":"10.1371\/journal.pone.0253859","volume":"16","author":"S Srikanth","year":"2021","unstructured":"Srikanth S, Jain L, Zepeda-Mendoza C, Cascio L, Jones K, Pauly R, et al. Position effects of 22q13 rearrangements on candidate genes in Phelan-McDermid syndrome. PLoS ONE. 2021;16:e0253859.","journal-title":"PLoS ONE"},{"key":"9708_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s11689-021-09370-5","volume":"13","author":"M Burdeus-Olavarrieta","year":"2021","unstructured":"Burdeus-Olavarrieta M, San Jos\u00e9-C\u00e1ceres A, Garc\u00eda-Alc\u00f3n A, Gonz\u00e1lez-Pe\u00f1as J, Hern\u00e1ndez-Jusdado P, Parellada-Redondo M. Characterisation of the clinical phenotype in Phelan-McDermid syndrome. J Neurodev Disord. 2021;13:26.","journal-title":"J Neurodev Disord"},{"key":"9708_CR43","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/gim.2013.144","volume":"16","author":"SM Sarasua","year":"2014","unstructured":"Sarasua SM, Dwivedi A, Boccuto L, Chen C-F, Sharp JL, Rollins JD, et al. 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan\u2013McDermid syndrome. Genet Med. 2014;16:318\u201328.","journal-title":"Genet Med"},{"key":"9708_CR44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s11689-016-9150-0","volume":"8","author":"RJ Zwanenburg","year":"2016","unstructured":"Zwanenburg RJ, Ruiter SAJ, van den Heuvel ER, Flapper BCT, Van Ravenswaaij-Arts CMA. Developmental phenotype in Phelan-McDermid (22q13.3 deletion) syndrome: a systematic and prospective study in 34 children. J Neurodev Disord. 2016;8:16.","journal-title":"J Neurodev Disord"},{"issue":"1","key":"9708_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13073-019-0623-0","volume":"11","author":"F Vetrini","year":"2019","unstructured":"Vetrini F, McKee S, Rosenfeld JA, Suri M, Lewis AM, Nugent KM, et al. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome. Genome Med. 2019;11(1):12.","journal-title":"Genome Med"},{"issue":"1","key":"9708_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s11689-024-09572-7","volume":"16","author":"L Asta","year":"2024","unstructured":"Asta L, Ricciardello A, Cucinotta F, Turriziani L, Boncoddo M, Bellomo F, et al. Clinical, developmental and serotonemia phenotyping of a sample of 70 Italian patients with Phelan-McDermid Syndrome. J Neurodev Disord. 2024;16(1):57.","journal-title":"J Neurodev Disord"},{"key":"9708_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13023-015-0323-9","volume":"10","author":"LM Oberman","year":"2015","unstructured":"Oberman LM, Boccuto L, Cascio L, Sarasua S, Kaufmann WE. Autism spectrum disorder in Phelan-McDermid syndrome: initial characterization and genotype-phenotype correlations. Orphanet J Rare Dis. 2015;10:105.","journal-title":"Orphanet J Rare Dis"},{"key":"9708_CR48","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/hmg\/ddab280","volume":"31","author":"T Levy","year":"2021","unstructured":"Levy T, Foss-Feig JH, Betancur C, Siper PM, Trelles-Thorne MdelP, Halpern D, et al. Strong evidence for genotype\u2013phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium. Hum Mol Genet. 2021;31:625\u201337.","journal-title":"Hum Mol Genet"},{"key":"9708_CR49","volume-title":"Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) Manual (Part II): Toddler module","author":"C Lord","year":"2012","unstructured":"Lord C, Luyster RJ, Gotham K, Guthrie W. Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) Manual (Part II): Toddler module. Torrance, CA: Western Psychological Services; 2012."},{"key":"9708_CR50","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/BF02172145","volume":"24","author":"C Lord","year":"1994","unstructured":"Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24:659\u201385.","journal-title":"J Autism Dev Disord"},{"key":"9708_CR51","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s10803-006-0213-z","volume":"37","author":"KSL Lam","year":"2007","unstructured":"Lam KSL, Aman MG. The Repetitive Behavior Scale-Revised: independent validation in individuals with autism spectrum disorders. J Autism Dev Disord. 2007;37:855\u201366.","journal-title":"J Autism Dev Disord"},{"key":"9708_CR52","first-page":"59","volume-title":"Sensory profile: User's manual","author":"DN McIntosh","year":"1999","unstructured":"McIntosh DN, Miller LJ, Shyu V. Development and validation of the Short Sensory Profile. In: Dunn W, editor. Sensory profile: User\u2019s manual. San Francisco, CA: Psychological Corporation; 1999. p. 59\u201373."},{"key":"9708_CR53","first-page":"485","volume":"89","author":"MG Aman","year":"1985","unstructured":"Aman MG, Singh NN, Stewart AW, Field CJ. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic. 1985;89:485\u201391.","journal-title":"Am J Ment Defic"},{"key":"9708_CR54","first-page":"429","volume-title":"The use of psychological testing for treatment planning and outcomes assessment","author":"TM Achenbach","year":"1999","unstructured":"Achenbach TM. The Child Behavior Checklist and related instruments. In: The use of psychological testing for treatment planning and outcomes assessment. 2nd ed. Mahwah, NJ, US: Lawrence Erlbaum Associates Publishers; 1999. p. 429\u201366.","edition":"2nd ed"},{"key":"9708_CR55","volume-title":"Vineland-II Adaptive Behavior Scales. Second Edition","author":"SS Sparrow","year":"2005","unstructured":"Sparrow SS, Cicchetti DV, Bella DA. Vineland-II Adaptive Behavior Scales. Second Edition. Eagan, MN: NCS Pearson; 2005."},{"key":"9708_CR56","volume-title":"The abilities of young children: a comprehensive system of mental measurement for the first eight years of life","author":"R Griffiths","year":"1984","unstructured":"Griffiths R. The abilities of young children: a comprehensive system of mental measurement for the first eight years of life. Revised Edition. Bukcs, UK: A.R.C.I.D. Test Agency Limited; 1984.","edition":"Revised Edition"},{"key":"9708_CR57","volume-title":"Wechsler intelligence scale for children \u2013 fourth edition (WISC-IV)","author":"D Wechsler","year":"2003","unstructured":"Wechsler D. Wechsler intelligence scale for children \u2013 fourth edition (WISC-IV). San Antonio, TX: The Psychological Corporation; 2003."},{"key":"9708_CR58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-3-319-50604-3_8","volume-title":"Handbook of Nonverbal Assessment [Internet]","author":"GH Roid","year":"2017","unstructured":"Roid GH, Koch C. Leiter-3: Nonverbal Cognitive and Neuropsychological Assessment. In: McCallum RS, editor. Handbook of Nonverbal Assessment [Internet]. Cham: Springer International Publishing; 2017. p. 127\u201350."},{"key":"9708_CR59","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1007\/s10803-017-3402-z","volume":"48","author":"H McConachie","year":"2018","unstructured":"McConachie H, Mason D, Parr JR, Garland D, Wilson C, Rodgers J. Enhancing the validity of a quality of life measure for autistic people. J Autism Dev Disord. 2018;48:1596\u2013611.","journal-title":"J Autism Dev Disord"},{"key":"9708_CR60","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1017\/S0033291798006667","volume":"28","author":"The WHOQOL Group","year":"1998","unstructured":"The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28:551\u20138.","journal-title":"Psychol Med"},{"issue":"8","key":"9708_CR61","doi-asserted-by":"publisher","first-page":"e1939","DOI":"10.1002\/mgg3.1939","volume":"10","author":"F Chehbani","year":"2022","unstructured":"Chehbani F, Tomaiuolo P, Picinelli C, Baccarin M, Castronovo P, Scattoni ML, et al. Yield of array-CGH analysis in Tunisian children with autism spectrum disorder. Mol Genet Genomic Med. 2022;10(8):e1939.","journal-title":"Mol Genet Genomic Med"},{"issue":"8","key":"9708_CR62","doi-asserted-by":"publisher","first-page":"e2182","DOI":"10.1002\/mgg3.2182","volume":"11","author":"F Cucinotta","year":"2023","unstructured":"Cucinotta F, Lintas C, Tomaiuolo P, Baccarin M, Picinelli C, Castronovo P, et al. Diagnostic yield and clinical impact of chromosomal microarray analysis in autism spectrum disorder. Mol Genet Genomic Med. 2023;11(8):e2182.","journal-title":"Mol Genet Genomic Med"},{"key":"9708_CR63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1755-8166-3-11","volume":"3","author":"NJ Neill","year":"2010","unstructured":"Neill NJ, Torchia BS, Bejjani BA, Shaffer LG, Ballif BC. Comparative analysis of copy number detection by whole-genome BAC and oligonucleotide array CGH. Mol Cytogenet. 2010;3:11.","journal-title":"Mol Cytogenet"},{"key":"9708_CR64","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1755-8166-4-13","volume":"4","author":"R Valli","year":"2011","unstructured":"Valli R, Marletta C, Pressato B, Montalbano G, Lo Curto F, Pasquali F, et al. Comparative genomic hybridization on microarray (a-CGH) in constitutional and acquired mosaicism may detect as low as 8% abnormal cells. Mol Cytogenet. 2011;4:13.","journal-title":"Mol Cytogenet"},{"key":"9708_CR65","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","volume":"5","author":"JN Mandrekar","year":"2010","unstructured":"Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5:1315\u20136.","journal-title":"J Thorac Oncol"},{"key":"9708_CR66","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2020","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2020."},{"issue":"7616","key":"9708_CR67","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285\u201391.","journal-title":"Nature"},{"key":"9708_CR68","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434\u201343.","journal-title":"Nature"},{"issue":"16","key":"9708_CR69","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1016\/j.cell.2022.06.036","volume":"185","author":"RL Collins","year":"2022","unstructured":"Collins RL, Glessner JT, Porcu E, Lepamets M, Brandon R, Lauricella C, et al. A cross-disorder dosage sensitivity map of the human genome. Cell. 2022;185(16):3041-3055.e25.","journal-title":"Cell"},{"issue":"1","key":"9708_CR70","first-page":"100145","volume":"4","author":"MS Breen","year":"2022","unstructured":"Breen MS, Fan X, Levy T, Pollak RM, Collins B, Osman A, et al. Large 22q13.3 deletions perturb peripheral transcriptomic and metabolomic profiles in Phelan-McDermid syndrome. HGG Adv. 2022;4(1):100145.","journal-title":"HGG Adv."},{"issue":"7","key":"9708_CR71","first-page":"839","volume":"40","author":"A Ziegler","year":"2019","unstructured":"Ziegler A, Colin E, Gouden\u00e8ge D, Bonneau D. A snapshot of some pLI score pitfalls. Hum Mutat. 2019;40(7):839\u201341.","journal-title":"Hum Mutat"},{"issue":"2","key":"9708_CR72","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/genes13020323","volume":"13","author":"MG Butler","year":"2022","unstructured":"Butler MG, Moreno-De-Luca D, Persico AM. Actionable genomics in clinical practice: paradigmatic case reports of clinical and therapeutic strategies based upon genetic testing. Genes (Basel). 2022;13(2):323.","journal-title":"Genes (Basel)"},{"key":"9708_CR73","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41431-020-00761-1","volume":"29","author":"A Brignell","year":"2021","unstructured":"Brignell A, Gu C, Holm A, Carrigg B, Sheppard DA, Amor DJ, et al. Speech and language phenotype in Phelan-McDermid (22q13.3) syndrome. Eur J Hum Genet. 2021;29:564\u201374.","journal-title":"Eur J Hum Genet"},{"key":"9708_CR74","doi-asserted-by":"publisher","first-page":"104745","DOI":"10.1016\/j.ejmg.2023.104745","volume":"66","author":"M Burdeus-Olavarrieta","year":"2023","unstructured":"Burdeus-Olavarrieta M, Nevado J, van Weering-Scholten S, Parker S, Swillen A. Consensus recommendations on communication, language and speech in Phelan-McDermid syndrome. Eur J Med Genet. 2023;66:104745.","journal-title":"Eur J Med Genet"},{"key":"9708_CR75","doi-asserted-by":"publisher","first-page":"652454","DOI":"10.3389\/fgene.2022.652454","volume":"13","author":"J Nevado","year":"2022","unstructured":"Nevado J, Garc\u00eda-Mi\u00f1a\u00far S, Palomares-Bralo M, Vallesp\u00edn E, Guill\u00e9n-Navarro E, Rosell J, et al. Variability in Phelan-McDermid syndrome in a cohort of 210 individuals. Front Genet. 2022;13:652454.","journal-title":"Front Genet"},{"key":"9708_CR76","doi-asserted-by":"publisher","first-page":"e0213921","DOI":"10.1371\/journal.pone.0213921","volume":"14","author":"CA Ziats","year":"2019","unstructured":"Ziats CA, Grosvenor LP, Sarasua SM, Thurm AE, Swedo SE, Mahfouz A, et al. Functional genomics analysis of Phelan-McDermid syndrome 22q13 region during human neurodevelopment. PLoS ONE. 2019;14:e0213921.","journal-title":"PLoS ONE"},{"key":"9708_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41525-017-0035-2","volume":"2","author":"A-C Tabet","year":"2017","unstructured":"Tabet A-C, Rolland T, Ducloy M, L\u00e9vy J, Buratti J, Mathieu A, et al. A framework to identify contributing genes in patients with Phelan-McDermid syndrome. NPJ Genom Med. 2017;2:1\u20139.","journal-title":"NPJ Genom Med"},{"key":"9708_CR78","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/YPG.0b013e328341e069","volume":"21","author":"C Waga","year":"2011","unstructured":"Waga C, Okamoto N, Ondo Y, Fukumura-Kato R, Goto Y-I, Kohsaka S, et al. Novel variants of the SHANK3 gene in Japanese autistic patients with severe delayed speech development. Psychiatr Genet. 2011;21:208\u201311.","journal-title":"Psychiatr Genet"},{"key":"9708_CR79","first-page":"6634584","volume":"2021","author":"C Manning","year":"2021","unstructured":"Manning C, Hurd PL, Read S, Crespi B. SHANK3 genotype mediates speech and language phenotypes in a nonclinical population. Autism Res Treat. 2021;2021:6634584.","journal-title":"Autism Res Treat"},{"key":"9708_CR80","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/acn3.50959","volume":"7","author":"S Jesse","year":"2020","unstructured":"Jesse S, M\u00fcller H-P, Schoen M, Asoglu H, Bockmann J, Huppertz H-J, et al. Severe white matter damage in SHANK3 deficiency: a human and translational study. Ann Clin Transl Neurol. 2020;7:46\u201358.","journal-title":"Ann Clin Transl Neurol"},{"key":"9708_CR81","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neuroscience.2017.09.011","volume":"364","author":"C Rollans","year":"2017","unstructured":"Rollans C, Cheema K, Georgiou GK, Cummine J. Pathways of the inferior frontal occipital fasciculus in overt speech and reading. Neuroscience. 2017;364:93\u2013106.","journal-title":"Neuroscience"},{"key":"9708_CR82","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41586-019-1278-0","volume":"570","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Sharma J, Ke Q, Landman R, Yuan J, Chen H, et al. Atypical behaviour and connectivity in SHANK3-mutant macaques. Nature. 2019;570:326\u201331.","journal-title":"Nature"},{"key":"9708_CR83","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrn.2016.183","volume":"18","author":"P Monteiro","year":"2017","unstructured":"Monteiro P, Feng G. SHANK proteins: roles at the synapse and in autism spectrum disorder. Nat Rev Neurosci. 2017;18:147\u201357.","journal-title":"Nat Rev Neurosci"},{"key":"9708_CR84","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13148-020-00990-7","volume":"13","author":"LC Schenkel","year":"2021","unstructured":"Schenkel LC, Aref-Eshghi E, Rooney K, Kerkhof J, Levy MA, McConkey H, et al. DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome. Clin Epigenetics. 2021;13:2.","journal-title":"Clin Epigenetics"},{"key":"9708_CR85","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.nbd.2018.12.011","volume":"124","author":"V Paternoster","year":"2019","unstructured":"Paternoster V, Svanborg M, Edhager AV, Rajkumar AP, Eickhardt EA, Pallesen J, et al. Brain proteome changes in female Brd1+\/- mice unmask dendritic spine pathology and show enrichment for schizophrenia risk. Neurobiol Dis. 2019;124:479\u201388.","journal-title":"Neurobiol Dis"},{"key":"9708_CR86","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.nlm.2017.03.009","volume":"141","author":"P Qvist","year":"2017","unstructured":"Qvist P, Rajkumar AP, Redrobe JP, Nyegaard M, Christensen JH, Mors O, et al. Mice heterozygous for an inactivated allele of the schizophrenia associated Brd1 gene display selective cognitive deficits with translational relevance to schizophrenia. Neurobiol Learn Mem. 2017;141:44\u201352.","journal-title":"Neurobiol Learn Mem"},{"key":"9708_CR87","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41398-020-00914-2","volume":"10","author":"AP Rajkumar","year":"2020","unstructured":"Rajkumar AP, Qvist P, Donskov JG, Lazarus R, Pallesen J, Nava N, et al. Reduced Brd1 expression leads to reversible depression-like behaviors and gene-expression changes in female mice. Transl Psychiatry. 2020;10:239.","journal-title":"Transl Psychiatry"},{"key":"9708_CR88","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.euroneuro.2012.01.005","volume":"22","author":"JH Christensen","year":"2012","unstructured":"Christensen JH, Elfving B, M\u00fcller HK, Fryland T, Nyegaard M, Corydon TJ, et al. The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress. Eur Neuropsychopharmacol. 2012;22:651\u20136.","journal-title":"Eur Neuropsychopharmacol"},{"key":"9708_CR89","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ajmg.10191","volume":"114","author":"TH Jorgensen","year":"2002","unstructured":"Jorgensen TH, B\u00f8rglum AD, Mors O, Wang AG, Pinaud M, Flint TJ, et al. Search for common haplotypes on chromosome 22q in patients with schizophrenia or bipolar disorder from the Faroe Islands. Am J Med Genet. 2002;114:245\u201352.","journal-title":"Am J Med Genet"},{"key":"9708_CR90","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.biopsych.2016.08.037","volume":"82","author":"P Qvist","year":"2017","unstructured":"Qvist P, Christensen JH, Vardya I, Rajkumar AP, M\u00f8rk A, Paternoster V, et al. The Schizophrenia-associated BRD1 gene regulates behavior, neurotransmission, and expression of schizophrenia risk enriched gene sets in mice. Biol Psychiatry. 2017;82:62\u201376.","journal-title":"Biol Psychiatry"},{"key":"9708_CR91","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13073-016-0308-x","volume":"8","author":"T Fryland","year":"2016","unstructured":"Fryland T, Christensen JH, Pallesen J, Mattheisen M, Palmfeldt J, Bak M, et al. Identification of the BRD1 interaction network and its impact on mental disorder risk. Genome Med. 2016;8:53.","journal-title":"Genome Med"},{"key":"9708_CR92","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3390\/genes13030528","volume":"13","author":"L Boccuto","year":"2022","unstructured":"Boccuto L, Mitz A, Abenavoli L, Sarasua SM, Bennett W, Rogers C, et al. Phenotypic variability in Phelan\u2013McDermid syndrome and its putative link to environmental factors. Genes. 2022;13:528.","journal-title":"Genes"},{"key":"9708_CR93","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.3390\/genes14111998","volume":"14","author":"S Shah","year":"2023","unstructured":"Shah S, Sarasua SM, Boccuto L, Dean BC, Wang L. Brain gene co-expression network analysis identifies 22q13 region genes associated with autism, intellectual disability, seizures, language impairment, and hypotonia. Genes (Basel). 2023;14:1998.","journal-title":"Genes (Basel)"},{"key":"9708_CR94","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ccell.2018.03.006","volume":"33","author":"Z Wang","year":"2018","unstructured":"Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang Y, et al. lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer. Cancer Cell. 2018;33:706-720.e9.","journal-title":"Cancer Cell"},{"issue":"23","key":"9708_CR95","doi-asserted-by":"publisher","first-page":"11463","DOI":"10.18632\/aging.102545","volume":"11","author":"J Sun","year":"2019","unstructured":"Sun J, Zheng J, Li Y, Yan M, Li P, Ma L. LncRNA EPIC1 downregulation mediates hydrogen peroxide-induced neuronal cell injury. Aging (Albany NY). 2019;11(23):11463\u201373.","journal-title":"Aging (Albany NY)"},{"key":"9708_CR96","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.celrep.2019.05.033","volume":"28","author":"Z Wei","year":"2019","unstructured":"Wei Z, Zhang M, Li C, Huang W, Fan Y, Guo J, et al. Specific TBC Domain-Containing Proteins Control the ER-Golgi-Plasma Membrane Trafficking of GPCRs. Cell Rep. 2019;28:554-566.e4.","journal-title":"Cell Rep"},{"key":"9708_CR97","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1471-2156-14-93","volume":"14","author":"N Belhedi","year":"2013","unstructured":"Belhedi N, Bena F, Mrabet A, Guipponi M, Souissi CB, Mrabet HK, et al. A new locus on chromosome 22q1331 linked to recessive genetic epilepsy with febrile seizures plus (GEFS+) in a Tunisian consanguineous family. BMC Genet. 2013;14:93.","journal-title":"BMC Genet"},{"key":"9708_CR98","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/cge.14074","volume":"101","author":"L Jain","year":"2022","unstructured":"Jain L, Oberman LM, Beamer L, Cascio L, May M, Srikanth S, et al. Genetic and metabolic profiling of individuals with Phelan-McDermid syndrome presenting with seizures. Clin Genet. 2022;101:87\u2013100.","journal-title":"Clin Genet"},{"key":"9708_CR99","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/pcn.12645","volume":"72","author":"H Sugawara","year":"2018","unstructured":"Sugawara H, Murata Y, Ikegame T, Sawamura R, Shimanaga S, Takeoka Y, et al. DNA methylation analyses of the candidate genes identified by a methylome-wide association study revealed common epigenetic alterations in schizophrenia and bipolar disorder. Psychiatry Clin Neurosci. 2018;72:245\u201354.","journal-title":"Psychiatry Clin Neurosci"},{"key":"9708_CR100","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1177\/08830738231204395","volume":"38","author":"Y Frank","year":"2023","unstructured":"Frank Y, Levy T, Lozano R, Friedman K, Underwood S, Kostic A, et al. Gait abnormalities in children with Phelan-McDermid syndrome. J Child Neurol. 2023;38:665\u201371.","journal-title":"J Child Neurol"},{"key":"9708_CR101","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/79911","volume":"26","author":"T Matsuura","year":"2000","unstructured":"Matsuura T, Yamagata T, Burgess DL, Rasmussen A, Grewal RP, Watase K, et al. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet. 2000;26:191\u20134.","journal-title":"Nat Genet"},{"key":"9708_CR102","doi-asserted-by":"publisher","first-page":"705182","DOI":"10.3389\/fcell.2021.705182","volume":"9","author":"MR Bentley-Ford","year":"2021","unstructured":"Bentley-Ford MR, Andersen RS, Croyle MJ, Haycraft CJ, Clearman KR, Foote JB, et al. ATXN10 is required for embryonic heart development and maintenance of epithelial cell phenotypes in the adult kidney and pancreas. Front Cell Dev Biol. 2021;9:705182.","journal-title":"Front Cell Dev Biol"},{"key":"9708_CR103","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/ajmg.a.38559","volume":"176","author":"P Palumbo","year":"2018","unstructured":"Palumbo P, Accadia M, Leone MP, Palladino T, Stallone R, Carella M, et al. Clinical and molecular characterization of an emerging chromosome 22q13.31 microdeletion syndrome. Am J Med Genet A. 2018;176:391\u20138.","journal-title":"Am J Med Genet A"},{"key":"9708_CR104","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0378-1119(97)00149-2","volume":"194","author":"F Schwartz","year":"1997","unstructured":"Schwartz F, Ota T. The 239AB gene on chromosome 22: a novel member of an ancient gene family. Gene. 1997;194:57\u201362.","journal-title":"Gene"},{"key":"9708_CR105","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00213-023-06355-1","volume":"240","author":"Y Liu","year":"2023","unstructured":"Liu Y, Shao J, Qiao R, Li J, Li C, Cao W. Xanthohumol improves cognitive impairment by regulating miRNA-532-3p\/Mpped1 in ovariectomized mice. Psychopharmacology. 2023;240:1169\u201378.","journal-title":"Psychopharmacology"},{"key":"9708_CR106","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1074\/jbc.M805996200","volume":"284","author":"R Tyagi","year":"2009","unstructured":"Tyagi R, Shenoy AR, Visweswariah SS. Characterization of an evolutionarily conserved metallophosphoesterase that is expressed in the fetal brain and associated with the WAGR syndrome. J Biol Chem. 2009;284:5217\u201328.","journal-title":"J Biol Chem"},{"key":"9708_CR107","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12929-023-00925-3","volume":"30","author":"Y-C Lin","year":"2023","unstructured":"Lin Y-C, Sahoo BK, Gau S-S, Yang R-B. The biology of SCUBE. J Biomed Sci. 2023;30:33.","journal-title":"J Biomed Sci"},{"key":"9708_CR108","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jez.b.21260","volume":"312B","author":"GM Xavier","year":"2009","unstructured":"Xavier GM, Sharpe PT, Cobourne MT. Scube1 is expressed during facial development in the mouse. J Exp Zool B Mol Dev Evol. 2009;312B:518\u201324.","journal-title":"J Exp Zool B Mol Dev Evol"},{"key":"9708_CR109","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.biopsych.2019.09.029","volume":"87","author":"C Cappi","year":"2020","unstructured":"Cappi C, Oliphant ME, P\u00e9ter Z, Zai G, Concei\u00e7\u00e3o do Ros\u00e1rio M, Sullivan CAW, et al. De novo damaging DNA coding mutations are associated with obsessive-compulsive disorder and overlap with Tourette\u2019s disorder and autism. Biol Psychiatry. 2020;87:1035\u201344.","journal-title":"Biol Psychiatry"},{"key":"9708_CR110","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1866-1955-6-39","volume":"6","author":"A Kolevzon","year":"2014","unstructured":"Kolevzon A, Angarita B, Bush L, Wang AT, Frank Y, Yang A, et al. Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring. J Neurodev Disord. 2014;6:39.","journal-title":"J Neurodev Disord"},{"key":"9708_CR111","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ejmg.2010.06.004","volume":"53","author":"C-P Chen","year":"2010","unstructured":"Chen C-P, Lin S-P, Chern S-R, Tsai F-J, Wu P-C, Lee C-C, et al. A de novo 7.9 Mb deletion in 22q13.2\u2192qter in a boy with autistic features, epilepsy, developmental delay, atopic dermatitis and abnormal immunological findings. Eur J Med Genet. 2010;53:329\u201332.","journal-title":"Eur J Med Genet"},{"key":"9708_CR112","doi-asserted-by":"publisher","first-page":"1203848","DOI":"10.3389\/fimmu.2023.1203848","volume":"14","author":"G Sentis","year":"2023","unstructured":"Sentis G, Loukogiannaki C, Malissovas N, Nikolopoulos D, Manolakou T, Flouda S, et al. A network-based approach reveals long non-coding RNAs associated with disease activity in lupus nephritis: key pathways for flare and potential biomarkers to be used as liquid biopsies. Front Immunol. 2023;14:1203848.","journal-title":"Front Immunol"},{"key":"9708_CR113","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/1878-0261.12446","volume":"13","author":"FO Beltr\u00e1n-Anaya","year":"2019","unstructured":"Beltr\u00e1n-Anaya FO, Romero-C\u00f3rdoba S, Rebollar-Vega R, Arrieta O, Bautista-Pi\u00f1a V, Dominguez-Reyes C, et al. Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death. Mol Oncol. 2019;13:909\u201327.","journal-title":"Mol Oncol"},{"key":"9708_CR114","doi-asserted-by":"publisher","first-page":"2676996","DOI":"10.1155\/2021\/2676996","volume":"2021","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, Tang C, Xu T, Zhao Z. Molecular analysis of prognosis and immune pathways of pancreatic cancer based on TNF family members. J Oncol. 2021;2021:2676996.","journal-title":"J Oncol"},{"key":"9708_CR115","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00404-022-06805-9","volume":"308","author":"P Li","year":"2023","unstructured":"Li P, Zhao Y. Integrative analysis of the immune-related ceRNA network in fetal growth restriction based on weighted gene co-expression network analysis. Arch Gynecol Obstet. 2023;308:1217\u201328.","journal-title":"Arch Gynecol Obstet"},{"key":"9708_CR116","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.62347\/GHKF1995","volume":"14","author":"X-Z Luan","year":"2024","unstructured":"Luan X-Z, Yuan S-X, Chen X-J, Zhou Y-R, Tang H, Li J-Q, et al. ODF3B affects the proliferation and apoptosis of glioma via the JAK\/STAT pathway. Am J Cancer Res. 2024;14:1419\u201332.","journal-title":"Am J Cancer Res"},{"key":"9708_CR117","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/brain\/awu408","volume":"138","author":"N Hoppmann","year":"2015","unstructured":"Hoppmann N, Graetz C, Paterka M, Poisa-Beiro L, Larochelle C, Hasan M, et al. New candidates for CD4 T cell pathogenicity in experimental neuroinflammation and multiple sclerosis. Brain. 2015;138:902\u201317.","journal-title":"Brain"},{"key":"9708_CR118","doi-asserted-by":"publisher","first-page":"5872","DOI":"10.1038\/ncomms6872","volume":"5","author":"Y Mishima","year":"2014","unstructured":"Mishima Y, Wang C, Miyagi S, Saraya A, Hosokawa H, Mochizuki-Kashio M, et al. Histone acetylation mediated by Brd1 is crucial for Cd8 gene activation during early thymocyte development. Nat Commun. 2014;5:5872.","journal-title":"Nat Commun"},{"issue":"1","key":"9708_CR119","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1186\/s12891-022-06098-8","volume":"23","author":"W Wang","year":"2022","unstructured":"Wang W, Ou Z, Peng J, Wang N, Zhou Y. Bioinformatics-based analysis of potential candidates chromatin regulators for immune infiltration in osteoarthritis. BMC Musculoskelet Disord. 2022;23(1):1123.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"9708_CR120","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1158\/0008-5472.CAN-20-1674","volume":"81","author":"C Wan","year":"2021","unstructured":"Wan C, Keany MP, Dong H, Al-Alem LF, Pandya UM, Lazo S, et al. Enhanced efficacy of simultaneous PD-1 and PD-L1 immune checkpoint blockade in high-grade serous ovarian cancer. Cancer Res. 2021;81(1):158\u201373.","journal-title":"Cancer Res"},{"key":"9708_CR121","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1177\/10738584241252576","volume":"30","author":"J Meng","year":"2024","unstructured":"Meng J, Zhang L, Zhang YW. Microglial dysfunction in Autism Spectrum Disorder. Neuroscientist. 2024;30:744\u201358.","journal-title":"Neuroscientist"},{"key":"9708_CR122","doi-asserted-by":"publisher","first-page":"1125428","DOI":"10.3389\/fnins.2023.1125428","volume":"17","author":"Y Xiong","year":"2023","unstructured":"Xiong Y, Chen J, Li Y. Microglia and astrocytes underlie neuroinflammation and synaptic susceptibility in autism spectrum disorder. Front Neurosci. 2023;17:1125428.","journal-title":"Front Neurosci"},{"key":"9708_CR123","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/genes13030504","volume":"13","author":"F Cammarata-Scalisi","year":"2022","unstructured":"Cammarata-Scalisi F, Callea M, Martinelli D, Willoughby CE, Tadich AC, Araya Castillo M, et al. Clinical and genetic aspects of Phelan\u2013McDermid syndrome: an interdisciplinary approach to management. Genes (Basel). 2022;13:504.","journal-title":"Genes (Basel)"},{"issue":"23","key":"9708_CR124","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1523\/JNEUROSCI.5381-06.2007","volume":"27","author":"S Deng","year":"2007","unstructured":"Deng S, Hirschberg A, Worzfeld T, Penachioni JY, Korostylev A, Swiercz JM, et al. Plexin-B2, but not Plexin-B1, critically modulates neuronal migration and patterning of the developing nervous system in vivo. J Neurosci. 2007;27(23):6333\u201347.","journal-title":"J Neurosci"},{"key":"9708_CR125","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.1523\/JNEUROSCI.4710-06.2007","volume":"27","author":"RH Friedel","year":"2007","unstructured":"Friedel RH, Kerjan G, Rayburn H, Sch\u00fcller U, Sotelo C, Tessier-Lavigne M, et al. Plexin-B2 controls the development of cerebellar granule cells. J Neurosci. 2007;27:3921\u201332.","journal-title":"J Neurosci"},{"key":"9708_CR126","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.mcn.2018.06.008","volume":"92","author":"JE McDermott","year":"2018","unstructured":"McDermott JE, Goldblatt D, Paradis S. Class 4 semaphorins and Plexin-B receptors regulate GABAergic and glutamatergic synapse development in the mammalian hippocampus. Mol Cell Neurosci. 2018;92:50\u201366.","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"9708_CR127","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.diff.2010.10.001","volume":"81","author":"N Per\u00e4l\u00e4","year":"2011","unstructured":"Per\u00e4l\u00e4 N, Jakobson M, Ola R, Fazzari P, Penachioni JY, Nymark M, et al. Sema4C-Plexin B2 signalling modulates ureteric branching in developing kidney. Differentiation. 2011;81(2):81\u201391.","journal-title":"Differentiation"},{"key":"9708_CR128","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00467-023-06146-y","volume":"39","author":"MD McCoy","year":"2024","unstructured":"McCoy MD, Sarasua SM, DeLuca JM, Davis S, Rogers RC, Phelan K, et al. Genetics of kidney disorders in Phelan-McDermid syndrome: evidence from 357 registry participants. Pediatr Nephrol. 2024;39:749\u201360.","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"9708_CR129","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/j.1349-7006.2011.01966.x","volume":"102","author":"N Mukaida","year":"2011","unstructured":"Mukaida N, Wang YY, Li YY. Roles of Pim-3, a novel survival kinase, in tumorigenesis. Cancer Sci. 2011;102(8):1437\u201342.","journal-title":"Cancer Sci"},{"key":"9708_CR130","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1634\/stemcells.2007-0066","volume":"25","author":"I Aksoy","year":"2007","unstructured":"Aksoy I, Sakabedoyan C, Bourillot P-Y, Malashicheva AB, Mancip J, Knoblauch K, et al. Self-renewal of murine embryonic stem cells is supported by the serine\/threonine kinases Pim-1 and Pim-3. Stem Cells. 2007;25:2996\u20133004.","journal-title":"Stem Cells"},{"key":"9708_CR131","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1093\/emboj\/18.12.3359","volume":"18","author":"U Konietzko","year":"1999","unstructured":"Konietzko U, Kauselmann G, Scafidi J, Staubli U, Mikkers H, Berns A, et al. Pim kinase expression is induced by LTP stimulation and required for the consolidation of enduring LTP. EMBO J. 1999;18:3359\u201369.","journal-title":"EMBO J"},{"key":"9708_CR132","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ymgme.2019.08.007","volume":"128","author":"S Tahata","year":"2019","unstructured":"Tahata S, Gunderson L, Lanpher B, Morava E. Complex phenotypes in ALG12-congenital disorder of glycosylation (ALG12-CDG): case series and review of the literature. Mol Genet Metab. 2019;128:409\u201314.","journal-title":"Mol Genet Metab"},{"key":"9708_CR133","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/ejhg.2013.210","volume":"22","author":"S Bohlega","year":"2014","unstructured":"Bohlega S, Al-Ajlan H, Al-Saif A. Mutation of fibulin-1 causes a novel syndrome involving the central nervous system and connective tissues. Eur J Hum Genet. 2014;22:640\u20133.","journal-title":"Eur J Hum Genet"},{"key":"9708_CR134","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/nn.4352","volume":"19","author":"SH Lelieveld","year":"2016","unstructured":"Lelieveld SH, Reijnders MR, Pfundt R, Yntema HG, Kamsteeg EJ, de Vries P, et al. Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability. Nat Neurosci. 2016;19:1194\u20136.","journal-title":"Nat Neurosci"},{"key":"9708_CR135","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/jmedgenet-2014-102582","volume":"51","author":"C Babbs","year":"2014","unstructured":"Babbs C, Lloyd D, Pagnamenta AT, Twigg SR, Green J, McGowan SJ, et al. De novo and rare inherited mutations implicate the transcriptional coregulator TCF20\/SPBP in autism spectrum disorder. J Med Genet. 2014;51:737\u201347.","journal-title":"J Med Genet"},{"key":"9708_CR136","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/ejhg.2016.90","volume":"24","author":"J Sch\u00e4fgen","year":"2016","unstructured":"Sch\u00e4fgen J, Cremer K, Becker J, Wieland T, Zink AM, Kim S, et al. De novo nonsense and frameshift variants of TCF20 in individuals with intellectual disability and postnatal overgrowth. Eur J Hum Genet. 2016;24:1739\u201345.","journal-title":"Eur J Hum Genet"},{"key":"9708_CR137","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3390\/genes13061042","volume":"13","author":"MD McCoy","year":"2022","unstructured":"McCoy MD, Sarasua SM, DeLuca JM, Davis S, Phelan K, Rogers RC, et al. State of the Science for Kidney Disorders in Phelan-McDermid Syndrome: UPK3A, FBLN1, WNT7B, and CELSR1 as Candidate Genes. Genes (Basel). 2022;13:1042.","journal-title":"Genes (Basel)"},{"key":"9708_CR138","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41419-021-03494-1","volume":"12","author":"Y Xia","year":"2021","unstructured":"Xia Y, Zhen L, Li H, Wang S, Chen S, Wang C, et al. MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway. Cell Death Dis. 2021;12:326.","journal-title":"Cell Death Dis"},{"key":"9708_CR139","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/cen.14087","volume":"91","author":"AE Butler","year":"2019","unstructured":"Butler AE, Hayat S, Dargham SR, Malek JA, Abdulla SA, Mohamoud YA, et al. Alterations in long noncoding RNAs in women with and without polycystic ovarian syndrome. Clin Endocrinol (Oxf). 2019;91:793\u20137.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9708_CR140","doi-asserted-by":"publisher","first-page":"2101310","DOI":"10.1002\/adbi.202101310","volume":"6","author":"D Das","year":"2022","unstructured":"Das D, Podder S. Deregulation of ceRNA networks in frontal cortex and choroid plexus of brain during SARS-CoV-2 infection aggravates neurological manifestations: an insight from bulk and single-cell transcriptomic analyses. Adv Biol. 2022;6:2101310.","journal-title":"Adv Biol"},{"key":"9708_CR141","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00467-013-2733-z","volume":"29","author":"K Halt","year":"2014","unstructured":"Halt K, Vainio S. Coordination of kidney organogenesis by Wnt signaling. Pediatr Nephrol. 2014;29:737\u201344.","journal-title":"Pediatr Nephrol"},{"key":"9708_CR142","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3389\/fnins.2019.00917","volume":"13","author":"A Shahapal","year":"2019","unstructured":"Shahapal A, Cho EB, Yong HJ, Jeong I, Kwak H, Lee JK, et al. FAM19A5 expression during embryogenesis and in the adult traumatic brain of FAM19A5-LacZ knock-in mice. Front Neurosci. 2019;13:917.","journal-title":"Front Neurosci"},{"key":"9708_CR143","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.bbrc.2019.12.119","volume":"523","author":"D Kang","year":"2020","unstructured":"Kang D, Kim HR, Kim KK, Kim DH, Jeong B, Jin S, et al. Brain-specific chemokine FAM19A5 induces hypothalamic inflammation. Biochem Biophys Res Commun. 2020;523:829\u201334.","journal-title":"Biochem Biophys Res Commun"},{"key":"9708_CR144","doi-asserted-by":"publisher","first-page":"8895900","DOI":"10.1155\/2020\/8895900","volume":"2020","author":"J Li","year":"2020","unstructured":"Li J, Li S, Song Y, Zhou W, Zhu X, Xu S, et al. Association of serum FAM19A5 with cognitive impairment in vascular dementia. Dis Markers. 2020;2020:8895900.","journal-title":"Dis Markers"},{"key":"9708_CR145","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1038\/s41380-020-0720-x","volume":"26","author":"S Huang","year":"2021","unstructured":"Huang S, Zheng C, Xie G, Song Z, Wang P, Bai Y, et al. FAM19A5\/TAFA5, a novel neurokine, plays a crucial role in depressive-like and spatial memory-related behaviors in mice. Mol Psychiatry. 2021;26:2363\u201379.","journal-title":"Mol Psychiatry"},{"key":"9708_CR146","doi-asserted-by":"publisher","first-page":"15575","DOI":"10.1038\/s41598-017-15586-0","volume":"7","author":"MY Park","year":"2017","unstructured":"Park MY, Kim HS, Lee M, Park B, Lee HY, Cho EB, et al. FAM19A5, a brain-specific chemokine, inhibits RANKL-induced osteoclast formation through formyl peptide receptor 2. Sci Rep. 2017;7:15575.","journal-title":"Sci Rep"},{"issue":"5","key":"9708_CR147","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41588-019-0383-1","volume":"51","author":"ZL Fuller","year":"2019","unstructured":"Fuller ZL, Berg JJ, Mostafavi H, Sella G, Przeworski M. Measuring intolerance to mutation in human genetics. Nat Genet. 2019;51(5):772\u20136.","journal-title":"Nat Genet"},{"issue":"7","key":"9708_CR148","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1136\/jmg-2023-109728","volume":"61","author":"CEL Smith","year":"2024","unstructured":"Smith CEL, Laugel-Haushalter V, Hany U, Best S, Taylor RL, Poulter JA, et al. Biallelic variants in Plexin B2 (PLXNB2) cause amelogenesis imperfecta, hearing loss and intellectual disability. J Med Genet. 2024;61(7):689\u201398.","journal-title":"J Med Genet"},{"issue":"4","key":"9708_CR149","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/ejhg.2008.195","volume":"17","author":"MC Bonaglia","year":"2009","unstructured":"Bonaglia MC, Giorda R, Beri S, Bigoni S, Sensi A, Baroncini A, et al. Mosaic 22q13 deletions: evidence for concurrent mosaic segmental isodisomy and gene conversion. Eur J Hum Genet. 2009;17(4):426\u201333.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"9708_CR150","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/jmedgenet-2017-105125","volume":"55","author":"N Kurtas","year":"2018","unstructured":"Kurtas N, Arrigoni F, Errichiello E, Zucca C, Maghini C, D\u2019Angelo MG, et al. Chromothripsis and ring chromosome 22: a paradigm of genomic complexity in the Phelan-McDermid syndrome (22q13 deletion syndrome). J Med Genet. 2018;55(4):269\u201377.","journal-title":"J Med Genet"}],"container-title":["Journal of Neurodevelopmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11689-026-09708-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-026-09708-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-026-09708-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:02:07Z","timestamp":1789603327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11689-026-09708-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":150,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9708"],"URL":"https:\/\/doi.org\/10.1186\/s11689-026-09708-x","relation":{},"ISSN":["1866-1955"],"issn-type":[{"value":"1866-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of University \u2018\u2018Campus Bio-Medico\u2019\u2019 of Rome, Italy (prot. n. 14\/98, first approval on April 28, 1998 and subsequent amendments) and the Ethics Committee of Messina, Italy (prot. n. 22\/17, approved on June 19, 2017). Written informed consent was obtained from caregivers of all participants included in this study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"53"}}